VXRT
Income statement / Annual
Last year (2024), Vaxart, Inc.'s total revenue was $28.70 M,
an increase of 288.94% from the previous year.
In 2024, Vaxart, Inc.'s net income was -$66.95 M.
See Vaxart, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
06/30/2017 |
06/30/2016 |
| Operating Revenue |
$28.70 M |
$7.38 M |
$107,000.00 |
$892,000.00 |
$4.05 M |
$9.86 M |
$4.16 M |
$5.84 M |
$8.90 M |
$9.30 M |
| Cost of Revenue |
$0.00
|
$68.14 M
|
$3.27 M
|
$48.75 M
|
$19.86 M
|
$14.54 M
|
$17.28 M
|
$12.36 M
|
$17.63 M
|
$100,000.00
|
| Gross Profit |
$28.70 M
|
-$60.76 M
|
-$3.16 M
|
-$47.86 M
|
-$15.82 M
|
-$4.68 M
|
-$13.12 M
|
-$6.52 M
|
-$8.73 M
|
$9.20 M
|
| Gross Profit Ratio |
1
|
-8.23
|
-29.53
|
-53.65
|
-3.91
|
-0.47
|
-3.15
|
-1.12
|
-0.98
|
0.99
|
| Research and Development Expenses |
$74.21 M
|
$68.14 M
|
$81.05 M
|
$48.75 M
|
$19.86 M
|
$14.54 M
|
$17.28 M
|
$12.36 M
|
$28.30 M
|
$26.30 M
|
| General & Administrative Expenses |
$20.78 M
|
$22.58 M
|
$29.39 M
|
$21.89 M
|
$15.20 M
|
$6.19 M
|
$6.68 M
|
$2.60 M
|
$5.70 M
|
$5.60 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$20.78 M
|
$22.58 M
|
$29.39 M
|
$21.89 M
|
$15.20 M
|
$6.19 M
|
$6.68 M
|
$2.60 M
|
$5.70 M
|
$5.60 M
|
| Other Expenses |
$0.00
|
$0.00
|
$6.96 M
|
$3.79 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$200,000.00
|
$100,000.00
|
| Operating Expenses |
$94.99 M
|
$90.73 M
|
$110.44 M
|
$70.64 M
|
$35.07 M
|
$20.73 M
|
$23.96 M
|
$83,000.00
|
$36.30 M
|
$34.30 M
|
| Cost And Expenses |
$94.99 M
|
$90.73 M
|
$110.44 M
|
$70.64 M
|
$35.07 M
|
$20.73 M
|
$23.96 M
|
$12.44 M
|
$36.30 M
|
$34.30 M
|
| Interest Income |
$2.54 M
|
$2.65 M
|
$1.25 M
|
$81,000.00
|
$75,000.00
|
$149,000.00
|
$58,000.00
|
$2.98 M
|
$0.00
|
$0.00
|
| Interest Expense |
$2.97 M
|
$1.45 M
|
$1.31 M
|
$1.48 M
|
$1.87 M
|
$2.39 M
|
$2.68 M
|
$0.00
|
$1.80 M
|
$300,000.00
|
| Depreciation & Amortization |
$8.85 M
|
$8.62 M
|
$3.27 M
|
$2.43 M
|
$1.85 M
|
$3.60 M
|
$3.20 M
|
$380,000.00
|
$100,000.00
|
$100,000.00
|
| EBITDA |
-$54.87 M |
-$72.13 M |
-$103.12 M |
-$66.45 M |
-$28.26 M |
-$12.17 M |
-$12.02 M |
-$8.74 M |
-$27.20 M |
-$25.00 M |
| EBITDA Ratio |
-1.91
|
-9.78
|
-963.73
|
-74.5
|
-6.99
|
-1.23
|
-2.89
|
-1.5
|
-3.06
|
-2.69
|
| Operating Income Ratio |
-2.31
|
-11.3
|
-1070.91
|
-81.56
|
-7.46
|
-1.6
|
-5.23
|
-1.56
|
-3.09
|
-2.71
|
| Total Other Income/Expenses Net |
-$395,000.00
|
$1.14 M
|
$6.90 M
|
$2.39 M
|
-$1.81 M
|
-$2.37 M
|
$3.86 M
|
-$467,000.00
|
-$1.70 M
|
-$200,000.00
|
| Income Before Tax |
-$66.69 M
|
-$82.20 M
|
-$107.69 M
|
-$70.36 M
|
-$31.98 M
|
-$18.16 M
|
-$17.90 M
|
-$9.58 M
|
-$29.10 M
|
-$25.40 M
|
| Income Before Tax Ratio |
-2.32
|
-11.14
|
-1006.46
|
-78.88
|
-7.9
|
-1.84
|
-4.3
|
-1.64
|
-3.27
|
-2.73
|
| Income Tax Expense |
$260,000.00
|
$261,000.00
|
$67,000.00
|
$107,000.00
|
$238,000.00
|
$490,000.00
|
$109,000.00
|
$2.88 M
|
$300,000.00
|
$400,000.00
|
| Net Income |
-$66.95 M
|
-$82.47 M
|
-$107.76 M
|
-$70.47 M
|
-$32.22 M
|
-$18.65 M
|
-$18.01 M
|
-$12.46 M
|
-$29.40 M
|
-$25.40 M
|
| Net Income Ratio |
-2.33
|
-11.18
|
-1007.08
|
-79
|
-7.96
|
-1.89
|
-4.33
|
-2.13
|
-3.3
|
-2.73
|
| EPS |
-0.0331 |
-0.057 |
-0.084 |
-0.058 |
-0.036 |
-0.086 |
-0.285 |
-0.329 |
-0.837 |
-0.723 |
| EPS Diluted |
-0.0331 |
-0.057 |
-0.084 |
-0.058 |
-0.036 |
-0.086 |
-0.285 |
-0.283 |
-0.837 |
-0.723 |
| Weighted Average Shares Out |
$2.02 B
|
$1.45 B
|
$1.28 B
|
$1.21 B
|
$882.96 M
|
$215.70 M
|
$63.16 M
|
$37.84 M
|
$35.13 M
|
$35.12 M
|
| Weighted Average Shares Out Diluted |
$2.02 B
|
$1.45 B
|
$1.28 B
|
$1.21 B
|
$882.96 M
|
$215.70 M
|
$63.16 M
|
$44.07 M
|
$35.13 M
|
$35.12 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
